Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Waldenstrom’s Macroglobulinaemia can mimic multiple myeloma, so accurate diagnosis is crucial.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Inflammation damages sweat ducts, causing sweat gland injury.

The dog recovered well from skin cancer and intestinal blockage after treatment.

Hodgkin's lymphoma can show up as hair loss.

Imatinib can cause hair loss due to lichen planopilaris.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

The patient had a severe allergic reaction to gold treatment.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

The role of γδT-cells in causing alopecia areata remains unclear.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

The assay effectively identifies compounds that affect immune cell activation.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

B cells can both help and hinder the body's defense against melanoma.